When Genenta Science listed on the Nasdaq at the tail end of 2021, the Milan-based biotech was squarely focused on its pipeline of cell-based gene therapies. | Four years after listing on the Nasdaq, ...
For a long time, investors were forced to select between big cryptocurrencies which moved slowly and new altcoin projects ...
GALVESTON, TX / ACCESS Newswire / January 12, 2026 / Callan JMB Inc. (NASDAQ:CJMB), a premier provider of vertically ...
Salesforce (NYSE:CRM) just secured two long-horizon deals signaling a strategic pivot beyond core CRM. The company announced ...
What’s your take on the Bill Belichick Hall of Fame “snub”? Head over to The Feed and weigh in with your answer and ...
Dante Moore is staying at Oregon, shaking up the 2026 NFL Draft. While others panic, the Cleveland Browns capitalize at No. 6 ...
By 2025, decentralized derivatives had become a major segment of DeFi, with dYdX positioned among its most influential ...
The development of China’s ice and snow economy has reached a critical inflection point, transitioning from a state-supported ...
Goldman Sachs is upgraded to BUY, with 10% total return potential and exceptional momentum following a strategic pivot. GS's ...
Metallus benefits from U.S. Army-backed funding, alongside $80 million in structural cost reductions and robust cash ...
Even the chancellor’s own son is pushing for a return to traditional snow days, but Kamar Samuels said the city is sticking ...
The Sacramento Kings are catching some flak at the NBA's midseason mark.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results